Investigating pancreatic cancer in elderly patients with new-onset diabetes
New Onset of DiabetEs in aSsociation With Pancreatic Cancer
This study is trying to see if a special test can help find pancreatic cancer earlier in older adults who have just been diagnosed with type 2 diabetes.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 2522 (estimated) |
| Ages | 60 Years and up |
| Sex | All |
| Sponsor | University of Pecs Academic / other |
| Locations | 1 site (Szeged, Csongrád) |
| Trial ID | NCT04164602 on ClinicalTrials.gov |
What this trial studies
This observational study aims to identify pancreatic cancer in patients over 60 years old who have been newly diagnosed with type 2 diabetes. Given the high risk of pancreatic cancer associated with new-onset diabetes, the study will utilize a specific biomarker panel to enhance early diagnosis. The research focuses on patients diagnosed with diabetes within the last six months, as early detection is crucial for improving treatment outcomes. The study seeks to address the challenges of late-stage diagnosis by targeting a high-risk population.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals over 60 years old who have been diagnosed with type 2 diabetes within the past six months.
Not a fit: Patients with chronic pancreatitis, previous pancreatic surgery, or other malignancies may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to earlier detection of pancreatic cancer, significantly improving survival rates for patients.
How similar studies have performed: Other studies have shown promise in using biomarker panels for early detection of pancreatic cancer, indicating that this approach may be effective.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * patients over 60 years of age * diabetes diagnosed within six months (newly diagnosed) * signed written informed consent Exclusion Criteria: * continous alcohol abuse * chronic pancreatitis * previous pancreas operation/pancreatectomy * pregnancy * present malignant disease
Where this trial is running
Szeged, Csongrád
- First Department of Medicine, Albert Szent-Györgyi Medical and Pharmaceutical Centre, University of Szeged — Szeged, Csongrád, Hungary (Recruiting)
Study contacts
- Principal investigator: László Czakó, MD, PhD, DSc — First Department of Medicine University of Szeged, HU
- Study coordinator: Dóra Illés, MD
- Email: olionx@gmail.com
- Phone: +36 20 232 93 65
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.